Skip to main content
. 2022 Jan 20;35(1):16–29. doi: 10.37201/req/172.2021

Table 2.

Adverse effects due to fluoroquinolones related to patients at incremental risk [61].

Adverse effect Patients at incremental risk
QT syndrome Treatment with non-potassium-sparing diuretics or significant baseline bradycardia
Tendonitis Older age, male, chronic renal disease, corticosteroid use
Retinal detachment Age, past history, cataract surgery
Aortic dissection Age, hypertension, congenital aortic valve anomalies, hereditary connective system disorders
Dysglycemias Advanced age, diabetes, renal insufficiency and concurrent use of hypoglycemic drugs (especially sulphonylureas)
Psychiatric effects Personal or family history